Martin Ebner is co-founder and member of the Board of LamKap Bio group.
He founded the Swiss bank BZ Bank AG in 1985 and owns 70 percent of its share capital. As an active investor Martin Ebner is the largest shareholder in the Swiss companies Vifor Pharma, Temenos and Intershop Holding AG. He is the controlling shareholder of Helvetic Airways and NovImmune/Light Chain Bioscience.
The investments are under the roof of Patinex AG and Anna Holding AG and are managed by Patinex Management AG.
Martin Ebner earned a degree in law (lic.iur.) from the University of Zurich, Switzerland, and a PhD in Business Administration from the University of Florida, USA.
